Treating the Blood: Stem Cell Transplant and Androgens

When Fanconi anemia (FA) begins to affect your child’s blood counts, the conversation shifts toward treatment. While there is currently no way to “fix” the genetic mutation in every cell of the body, there are highly effective ways to treat the bone marrow and blood. These range from temporary “boosts” to a complex, potentially curative transplant.

The Definitive Treatment for the Blood: Stem Cell Transplant

An Allogeneic Hematopoietic Stem Cell Transplant (HSCT) is currently the established curative treatment for severe FA-associated bone marrow failure and substantially reduces the risk of FA-related leukemia (AML) ^[1].

It is important to understand two key things about HSCT:

1. What it treats: It replaces the “broken” stem cells in the bone marrow with healthy ones from a donor. When successful, this cures the bone marrow failure ^[1]. However, post-transplant complications like graft failure, relapse of pre-existing disease, or secondary malignancies can still occur.
2. What it does NOT fix: It does not change the FA mutation in the rest of the body’s tissues (like the skin, throat, or organs). This means that even after a successful transplant, your child will still need lifelong screening for solid tumors ^[2][3].

What to expect from HSCT: The transplant process involves a lengthy hospital stay in isolation to prevent infections. The conditioning can impact fertility, so fertility preservation options should be discussed beforehand. Long-term follow-up is critical to monitor for Graft-Versus-Host Disease (GVHD), organ toxicity, and secondary cancers.

The Importance of Individualized Conditioning

In a typical transplant for acquired aplastic anemia, patients may receive conditioning regimens that include high doses of chemotherapy and sometimes radiation to “clear out” the old marrow. However, because FA cells are uniquely sensitive to DNA damage, standard conditioning can cause life-threatening toxicity or organ damage ^[4].

Instead, an FA-experienced transplant center must individualize a Reduced-Intensity Conditioning (RIC) regimen. This approach typically uses lower-than-normal doses of carefully selected agents (like fludarabine and low-dose cyclophosphamide) designed to protect fragile cells while allowing donor cells to engraft ^[5][6]. Protocols vary widely by donor, age, disease status, and center, and even reduced intensity still carries serious toxicity risks ^[7]. Before a relative is considered as a donor, they must undergo appropriate FA genetic testing to ensure they are not affected.

Survival Rates and Donor Types

The success of a transplant depends heavily on the “match” (HLA typing) between your child and the donor, as well as their disease status prior to transplant. Published outcomes vary significantly by era, center, and whether the patient has marrow failure versus MDS/AML ^[8]:

• Matched Sibling Donor: This remains the gold standard, historically offering the best survival outcomes and lowest risk of severe GVHD ^[8].
• Matched Unrelated Donor (MUD): If a sibling isn’t a match, a well-matched donor from a registry is often considered.
• Alternative Donors: Using mismatched or “half-matched” (haploidentical) family members carries different risk profiles, though specialized techniques to remove certain immune cells are continually improving outcomes ^[8][9]. Discuss center-specific, diagnosis-specific outcomes with your transplant team.

Androgen Therapy: A Bridge, Not a Cure

For some families, a transplant may not be appropriate immediately, or a donor may not be available. In these cases, doctors may prescribe androgens (synthetic hormones), such as oxymetholone ^[10].

Androgens can stimulate the bone marrow to produce more red blood cells and platelets in some patients ^[10][11]. However, responses are highly variable, often temporary, and do not prevent clonal evolution or progression to MDS/AML. It is not appropriate for every child.

Androgen therapy requires specialist-directed monitoring due to significant side effects ^[10][11]:

• Liver Health: Androgens can cause liver toxicity, blood-filled cysts (peliosis), and the growth of liver tumors (adenomas). Your child will need regular liver ultrasounds and blood tests ^[10][12].
• Physical Changes: These hormones can cause “virilization,” which includes acne, unwanted hair growth, and a deepening of the voice ^[10].
• Growth Effects: They can also cause premature epiphyseal closure (stopping bone growth sooner than expected) or alter lipid profiles, requiring regular checks by an endocrinologist ^[13].

The Future: Gene Therapy

There is a great deal of excitement around gene therapy, which is currently being studied in early-phase clinical trials. This process involves taking your child’s own stem cells, using a harmless viral vector to “insert” a functional copy of the FANC gene into them, and then giving the cells back ^[14].

Early results are promising, showing that some children have been able to stabilize their blood counts and defer a transplant ^[14]. However, gene therapy is not yet a standard treatment and is only available through specialized research trials ^[1]. It is still being determined how long these cells will last and whether they provide the same long-term protection as a donor transplant ^[14].